Physician profile
Michael E Prater
NPI 1598723173
$1,871.46
in general payments reported to CMS, 2019-2025
19 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27.48 · 2020: $125 · 2021: $332 · 2022: $276 · 2023: $335 · 2024: $331 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $470.88 | 2021-2025 | |
| Glaxosmithkline, LLC. | $424.35 | 2020-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $345.54 | 2019-2025 | Dupixent |
| Optinose US, INC. | $215.05 | 2020-2022 | |
| Baxter Healthcare | $74.84 | 2023 | |
| Merck Sharp & Dohme LLC | $54.86 | 2023-2025 | Keytruda |
| Novartis Pharmaceuticals Corporation | $50.31 | 2021-2023 | |
| Integra Lifesciences Corporation | $27.42 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Acclarent, INC | $24.77 | 2019-2020 | |
| Medtronic, INC. | $24.52 | 2024 | Pteye Parathyroid Detection System |
| Itamar Medical INC | $24.03 | 2022 | |
| Covidien LP | $21.37 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $20.54 | 2025 | Tezspire |
| Abbvie INC. | $19.49 | 2021 | |
| Stryker Corporation | $16.02 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $15.48 | 2022 | |
| Intersect Ent, INC. | $14.79 | 2021 | |
| Phadia US INC. | $14.39 | 2020 | |
| Forte Bio-Pharma LLC | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Prater listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.